{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:41:59Z","timestamp":1776361319014,"version":"3.51.2"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pharma.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:06:45Z","timestamp":1765901205000},"page":"539-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plan de continuit\u00e9 et de reprise d\u2019activit\u00e9 d\u2019une st\u00e9rilisation\u00a0: comment est-il int\u00e9gr\u00e9 au syst\u00e8me management de la qualit\u00e9\u00a0?"],"prefix":"10.1016","volume":"84","author":[{"given":"Clo\u00e9","family":"Chabanol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Princet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Rodier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle","family":"Aigrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2025.12.009_bib0060","unstructured":"France. Code de la sant\u00e9 publique\u00a0\u2013\u00a0Section 3\u00a0: st\u00e9rilisation des dispositifs m\u00e9dicaux (Articles R6111-18\u00a0\u00e0 R6111-21-1) [Internet]. L\u00e9gifrance\u00a0; [cit\u00e9 2025\u00a0d\u00e9cembre 02]. Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/codes\/section_lc\/LEGITEXT000006072665\/LEGISCTA000006190788\/."},{"key":"10.1016\/j.pharma.2025.12.009_bib0065","series-title":"Bonnes pratiques de pharmacie hospitali\u00e8re","year":"2001"},{"key":"10.1016\/j.pharma.2025.12.009_bib0070","series-title":"Guide bonnes pratiques de st\u00e9rilisation des dispositifs m\u00e9dicaux r\u00e9utilisables","year":"2021"},{"key":"10.1016\/j.pharma.2025.12.009_bib0075","unstructured":"ISO. NF EN ISO 9001\u00a0: syst\u00e8mes de management de la qualit\u00e9\u00a0\u2013\u00a0Exigences. \u00c9d. oct. 2015."},{"issue":"6\u20137","key":"10.1016\/j.pharma.2025.12.009_bib0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.canrad.2022.06.011","article-title":"Cyberattaque \u00e0 l\u2019h\u00f4pital de Dax\u00a0: exposition des faits, cons\u00e9quences et retour d\u2019exp\u00e9rience","volume":"26","author":"Pontier","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.pharma.2025.12.009_bib0085","series-title":"32 Comment limiter l\u2019impact d\u2019une cyberattaque sur le fonctionnement d\u2019une st\u00e9rilisation\u202f? [Internet]","author":"Chapalain","year":"2024"},{"key":"10.1016\/j.pharma.2025.12.009_bib0090","unstructured":"Cybers\u00e9curit\u00e9 en sant\u00e9: plus d\u2019incidents signal\u00e9s en 2024, mais moins de d\u00e9g\u00e2ts, les h\u00f4pitaux se d\u00e9fendent mieux [Internet]. What's up Doc; [cit\u00e9 6\u00a0septembre 2025]. Disponible sur\u00a0: https:\/\/www.whatsupdoc-lemag.fr\/article\/cybersecurite-en-sante-plus-dincidents-signales-en-2024-mais-moins-de-degats-les-hopitaux."},{"issue":"2","key":"10.1016\/j.pharma.2025.12.009_bib0095","first-page":"60","article-title":"Retour d\u2019exp\u00e9rience, CHU de Rouen confront\u00e9 \u00e0 une attaque en 2019","volume":"29","author":"Hamelin","year":"2021","journal-title":"J Droit Sante Assurance Mal"},{"issue":"5","key":"10.1016\/j.pharma.2025.12.009_bib0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pharma.2019.05.002","article-title":"9001\u00a0d\u2019un service de st\u00e9rilisation\u00a0: passage \u00e0 la version 2015","volume":"77","author":"Maurin","year":"2019","journal-title":"Ann Pharm Fr"},{"issue":"1","key":"10.1016\/j.pharma.2025.12.009_bib0105","first-page":"e14","article-title":"Faire face \u00e0 une cyberattaque\u00a0: retour d\u2019exp\u00e9rience d\u2019une unit\u00e9 de reconstitution des chimioth\u00e9rapies","volume":"59","author":"Scius","year":"2024","journal-title":"Pharm Clin"},{"issue":"1","key":"10.1016\/j.pharma.2025.12.009_bib0055","first-page":"8","article-title":"Communiquer dans une situation d\u00e9grad\u00e9e\u00a0: se pr\u00e9parer \u00e0 une cyber-attaque","volume":"8","author":"Raux","year":"2024","journal-title":"Med Catastr Urg Collect"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450925002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:45:29Z","timestamp":1776357929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450925002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0003450925002184"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2025.12.009","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plan de continuit\u00e9 et de reprise d\u2019activit\u00e9 d\u2019une st\u00e9rilisation\u00a0: comment est-il int\u00e9gr\u00e9 au syst\u00e8me management de la qualit\u00e9\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}